Fred van Leuven
Corporate Officer/Principal bij Katholieke Universiteit Leuven
Actieve functies van Fred van Leuven
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
Loopbaan van Fred van Leuven
Eerdere bekende functies van Fred van Leuven
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AC IMMUNE SA | Oprichter | 13-02-2003 | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Oprichter | 01-01-2002 | - |
Opleiding van Fred van Leuven
| Ghent University | Graduate Degree |
Statistieken
Internationaal
| België | 4 |
| Zwitserland | 2 |
Operationeel
| Founder | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Beurs
- Insiders
- Fred van Leuven
- Ervaring
